Evidence map›Paper›PMID 38630083›Full record

ReviewInfectious microbes & diseases2020

The Correlation Between Heart Failure and Gut Microbiome Metabolites.

Lina Chen, Senhao Li, Lanmu Ai, Jun Zhou, Junlin Huang, Feng Xu, Xiangyuan Zeng, Jia Han, Fangxue Yin, Yixin Zhu and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Infectious microbes & diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. The Need forCJC open · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Lina ChenShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Senhao LiShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Lanmu AiCollege of Medicine, Shaoxing University, Shaoxing, Zhejiang, China.
Jun ZhouShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Junlin HuangCollege of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.
Feng XuShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Xiangyuan ZengShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Jia HanShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Fangxue YinShulan International Medical College, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Hangzhou, Zhejiang, China.
Yixin ZhuShulan International Medical College, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Hangzhou, Zhejiang, China.
Yifang XieShaoxing City Keqiao District Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang, China.
Shaoxing People's Hospital · CNZhejiang Shuren University · CNShaoxing University · CNUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF) is a global public health problem, with morbidity and mortality increasing year by year. The gut microbiome actively affects the physiological and pathological activities of the human body in a variety of ways. More and more studies have suggested a strong correlation between HF and gut microbiome metabolites. Our review summarizes the specific alteration of these metabolites and their connection to the progression of HF, aiming at considering new approaches toward regulating the gut microbiome and using its metabolic pathways to treat HF, potentially decreasing the morbidity and mortality of HF as well as improving prognosis.

Indexed as

bile acidheart failuremicrobiomeshort chain fatty acidtrimethylamine N-oxide

Identifiers

PMID38630083
PMCPMC7769059
OpenAlexW3112341072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.